1 Report Overview

• 1.1 Study Scope
• 1.2 Market Analysis by Type
  • 1.2.1 Global Companion Diagnostic Technologies Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
  • 1.2.2 Immunohistochemistry
  • 1.2.3 Molecular Diagnostics
• 1.3 Market by Application
  • 1.3.1 Global Companion Diagnostic Technologies Market Share by Application: 2016 VS 2021 VS 2027
  • 1.3.2 Oncology
  • 1.3.3 Cardiovascular
  • 1.3.4 Central Nervous System
  • 1.3.5 Auto immune & Inflammation
  • 1.3.6 Virology
  • 1.3.7 Others
• 1.4 Study Objectives
• 1.5 Years Considered

2 Global Growth Trends

• 2.1 Global Companion Diagnostic Technologies Market Perspective (2016-2027)
• 2.2 Companion Diagnostic Technologies Growth Trends by Regions
  • 2.2.1 Companion Diagnostic Technologies Market Size by Regions: 2016 VS 2021 VS 2027
  • 2.2.2 Companion Diagnostic Technologies Historic Market Share by Regions (2016-2021)
  • 2.2.3 Companion Diagnostic Technologies Forecasted Market Size by Regions (2022-2027)
• 2.3 Companion Diagnostic Technologies Industry Dynamic
  • 2.3.1 Companion Diagnostic Technologies Market Trends
  • 2.3.2 Companion Diagnostic Technologies Market Drivers
  • 2.3.3 Companion Diagnostic Technologies Market Challenges
  • 2.3.4 Companion Diagnostic Technologies Market Restraints

3 Competition Landscape by Key Players

• 3.1 Global Top Companion Diagnostic Technologies Players by Revenue
  • 3.1.1 Global Top Companion Diagnostic Technologies Players by Revenue (2016-2021)
  • 3.1.2 Global Companion Diagnostic Technologies Revenue Market Share by Players (2016-2021)
• 3.2 Global Companion Diagnostic Technologies Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
• 3.3 Players Covered: Ranking by Companion Diagnostic Technologies Revenue
• 3.4 Global Companion Diagnostic Technologies Market Concentration Ratio
  • 3.4.1 Global Companion Diagnostic Technologies Market Concentration Ratio (CR5 and HHI)
  • 3.4.2 Global Top 10 and Top 5 Companies by Companion Diagnostic Technologies Revenue in 2020
• 3.5 Companion Diagnostic Technologies Key Players Head office and Area Served
• 3.6 Key Players Companion Diagnostic Technologies Product Solution and Service
• 3.7 Date of Enter into Companion Diagnostic Technologies Market
• 3.8 Mergers & Acquisitions, Expansion Plans

4 Companion Diagnostic Technologies Breakdown Data by Type

• 4.1 Global Companion Diagnostic Technologies Historic Market Size by Type (2016-2021)
• 4.2 Global Companion Diagnostic Technologies Forecasted Market Size by Type (2022-2027)

5 Companion Diagnostic Technologies Breakdown Data by Application

• 5.1 Global Companion Diagnostic Technologies Historic Market Size by Application (2016-2021)
• 5.2 Global Companion Diagnostic Technologies Forecasted Market Size by Application (2022-2027)

6 North America

• 6.1 North America Companion Diagnostic Technologies Market Size (2016-2027)
• 6.2 North America Companion Diagnostic Technologies Market Size by Type
  • 6.2.1 North America Companion Diagnostic Technologies Market Size by Type (2016-2021)
  • 6.2.2 North America Companion Diagnostic Technologies Market Size by Type (2022-2027)
  • 6.2.3 North America Companion Diagnostic Technologies Market Size by Type (2016-2027)
• 6.3 North America Companion Diagnostic Technologies Market Size by Application
  • 6.3.1 North America Companion Diagnostic Technologies Market Size by Application (2016-2021)
  • 6.3.2 North America Companion Diagnostic Technologies Market Size by Application (2022-2027)
  • 6.3.3 North America Companion Diagnostic Technologies Market Size by Application (2016-2027)
• 6.4 North America Companion Diagnostic Technologies Market Size by Country
  • 6.4.1 North America Companion Diagnostic Technologies Market Size by Country (2016-2021)
  • 6.4.2 North America Companion Diagnostic Technologies Market Size by Country (2022-2027)
  • 6.4.3 United States
  • 6.4.3 Canada

7 Europe

• 7.1 Europe Companion Diagnostic Technologies Market Size (2016-2027)
• 7.2 Europe Companion Diagnostic Technologies Market Size by Type
  • 7.2.1 Europe Companion Diagnostic Technologies Market Size by Type (2016-2021)
  • 7.2.2 Europe Companion Diagnostic Technologies Market Size by Type (2022-2027)
  • 7.2.3 Europe Companion Diagnostic Technologies Market Size by Type (2016-2027)
• 7.3 Europe Companion Diagnostic Technologies Market Size by Application
  • 7.3.1 Europe Companion Diagnostic Technologies Market Size by Application (2016-2021)
  • 7.3.2 Europe Companion Diagnostic Technologies Market Size by Application (2022-2027)
  • 7.3.3 Europe Companion Diagnostic Technologies Market Size by Application (2016-2027)
• 7.4 Europe Companion Diagnostic Technologies Market Size by Country
  • 7.4.1 Europe Companion Diagnostic Technologies Market Size by Country (2016-2021)
  • 7.4.2 Europe Companion Diagnostic Technologies Market Size by Country (2022-2027)
  • 7.4.3 Germany
  • 7.4.4 France
  • 7.4.5 U.K.
  • 7.4.6 Italy
  • 7.4.7 Russia
  • 7.4.8 Nordic

8 Asia-Pacific

• 8.1 Asia-Pacific Companion Diagnostic Technologies Market Size (2016-2027)
• 8.2 Asia-Pacific Companion Diagnostic Technologies Market Size by Type
  • 8.2.1 Asia-Pacific Companion Diagnostic Technologies Market Size by Type (2016-2021)
  • 8.2.2 Asia-Pacific Companion Diagnostic Technologies Market Size by Type (2022-2027)
  • 8.2.3 Asia-Pacific Companion Diagnostic Technologies Market Size by Type (2016-2027)
• 8.3 Asia-Pacific Companion Diagnostic Technologies Market Size by Application
  • 8.3.1 Asia-Pacific Companion Diagnostic Technologies Market Size by Application (2016-2021)
  • 8.3.2 Asia-Pacific Companion Diagnostic Technologies Market Size by Application (2022-2027)
  • 8.3.3 Asia-Pacific Companion Diagnostic Technologies Market Size by Application (2016-2027)
• 8.4 Asia-Pacific Companion Diagnostic Technologies Market Size by Region
  • 8.4.1 Asia-Pacific Companion Diagnostic Technologies Market Size by Region (2016-2021)
  • 8.4.2 Asia-Pacific Companion Diagnostic Technologies Market Size by Region (2022-2027)
  • 8.4.3 China
  • 8.4.4 Japan
  • 8.4.5 South Korea
  • 8.4.6 Southeast Asia
  • 8.4.7 India
  • 8.4.8 Australia

9 Latin America

• 9.1 Latin America Companion Diagnostic Technologies Market Size (2016-2027)
• 9.2 Latin America Companion Diagnostic Technologies Market Size by Type
  • 9.2.1 Latin America Companion Diagnostic Technologies Market Size by Type (2016-2021)
  • 9.2.2 Latin America Companion Diagnostic Technologies Market Size by Type (2022-2027)
  • 9.2.3 Latin America Companion Diagnostic Technologies Market Size by Type (2016-2027)
• 9.3 Latin America Companion Diagnostic Technologies Market Size by Application
  • 9.3.1 Latin America Companion Diagnostic Technologies Market Size by Application (2016-2021)
  • 9.3.2 Latin America Companion Diagnostic Technologies Market Size by Application (2022-2027)
  • 9.3.3 Latin America Companion Diagnostic Technologies Market Size by Application (2016-2027)
• 9.4 Latin America Companion Diagnostic Technologies Market Size by Country
  • 9.4.1 Latin America Companion Diagnostic Technologies Market Size by Country (2016-2021)
  • 9.4.2 Latin America Companion Diagnostic Technologies Market Size by Country (2022-2027)
  • 9.4.3 Mexico
  • 9.4.4 Brazil

10 Middle East & Africa

• 10.1 Middle East & Africa Companion Diagnostic Technologies Market Size (2016-2027)
• 10.2 Middle East & Africa Companion Diagnostic Technologies Market Size by Type
  • 10.2.1 Middle East & Africa Companion Diagnostic Technologies Market Size by Type (2016-2021)
  • 10.2.2 Middle East & Africa Companion Diagnostic Technologies Market Size by Type (2022-2027)
  • 10.2.3 Middle East & Africa Companion Diagnostic Technologies Market Size by Type (2016-2027)
• 10.3 Middle East & Africa Companion Diagnostic Technologies Market Size by Application
  • 10.3.1 Middle East & Africa Companion Diagnostic Technologies Market Size by Application (2016-2021)
  • 10.3.2 Middle East & Africa Companion Diagnostic Technologies Market Size by Application (2022-2027)
  • 10.3.3 Middle East & Africa Companion Diagnostic Technologies Market Size by Application (2016-2027)
• 10.4 Middle East & Africa Companion Diagnostic Technologies Market Size by Country
  • 10.4.1 Middle East & Africa Companion Diagnostic Technologies Market Size by Country (2016-2021)
  • 10.4.2 Middle East & Africa Companion Diagnostic Technologies Market Size by Country (2022-2027)
  • 10.4.3 Turkey
  • 10.4.4 Saudi Arabia
  • 10.4.5 UAE

11 Key Players Profiles

• 11.1 Dako (Agilent Technologies)
  • 11.1.1 Dako (Agilent Technologies) Company Details
  • 11.1.2 Dako (Agilent Technologies) Business Overview
  • 11.1.3 Dako (Agilent Technologies) Companion Diagnostic Technologies Introduction
  • 11.1.4 Dako (Agilent Technologies) Revenue in Companion Diagnostic Technologies Business (2016-2021)
  • 11.1.5 Dako (Agilent Technologies) Recent Development
• 11.2 Qiagen
  • 11.2.1 Qiagen Company Details
  • 11.2.2 Qiagen Business Overview
  • 11.2.3 Qiagen Companion Diagnostic Technologies Introduction
  • 11.2.4 Qiagen Revenue in Companion Diagnostic Technologies Business (2016-2021)
  • 11.2.5 Qiagen Recent Development
• 11.3 Roche
  • 11.3.1 Roche Company Details
  • 11.3.2 Roche Business Overview
  • 11.3.3 Roche Companion Diagnostic Technologies Introduction
  • 11.3.4 Roche Revenue in Companion Diagnostic Technologies Business (2016-2021)
  • 11.3.5 Roche Recent Development
• 11.4 Abbott Laboratories
  • 11.4.1 Abbott Laboratories Company Details
  • 11.4.2 Abbott Laboratories Business Overview
  • 11.4.3 Abbott Laboratories Companion Diagnostic Technologies Introduction
  • 11.4.4 Abbott Laboratories Revenue in Companion Diagnostic Technologies Business (2016-2021)
  • 11.4.5 Abbott Laboratories Recent Development
• 11.5 Thermo Fisher Scientific
  • 11.5.1 Thermo Fisher Scientific Company Details
  • 11.5.2 Thermo Fisher Scientific Business Overview
  • 11.5.3 Thermo Fisher Scientific Companion Diagnostic Technologies Introduction
  • 11.5.4 Thermo Fisher Scientific Revenue in Companion Diagnostic Technologies Business (2016-2021)
  • 11.5.5 Thermo Fisher Scientific Recent Development
• 11.6 bioMerieux
  • 11.6.1 bioMerieux Company Details
  • 11.6.2 bioMerieux Business Overview
  • 11.6.3 bioMerieux Companion Diagnostic Technologies Introduction
  • 11.6.4 bioMerieux Revenue in Companion Diagnostic Technologies Business (2016-2021)
  • 11.6.5 bioMerieux Recent Development
• 11.7 Myriad Genetics
  • 11.7.1 Myriad Genetics Company Details
  • 11.7.2 Myriad Genetics Business Overview
  • 11.7.3 Myriad Genetics Companion Diagnostic Technologies Introduction
  • 11.7.4 Myriad Genetics Revenue in Companion Diagnostic Technologies Business (2016-2021)
  • 11.7.5 Myriad Genetics Recent Development
• 11.8 Resonance Health Ltd.
  • 11.8.1 Resonance Health Ltd. Company Details
  • 11.8.2 Resonance Health Ltd. Business Overview
  • 11.8.3 Resonance Health Ltd. Companion Diagnostic Technologies Introduction
  • 11.8.4 Resonance Health Ltd. Revenue in Companion Diagnostic Technologies Business (2016-2021)
  • 11.8.5 Resonance Health Ltd. Recent Development
• 11.9 Leica Microsystems
  • 11.9.1 Leica Microsystems Company Details
  • 11.9.2 Leica Microsystems Business Overview
  • 11.9.3 Leica Microsystems Companion Diagnostic Technologies Introduction
  • 11.9.4 Leica Microsystems Revenue in Companion Diagnostic Technologies Business (2016-2021)
  • 11.9.5 Leica Microsystems Recent Development
• 11.10 Danaher
  • 11.10.1 Danaher Company Details
  • 11.10.2 Danaher Business Overview
  • 11.10.3 Danaher Companion Diagnostic Technologies Introduction
  • 11.10.4 Danaher Revenue in Companion Diagnostic Technologies Business (2016-2021)
  • 11.10.5 Danaher Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix

• 13.1 Research Methodology
  • 13.1.1 Methodology/Research Approach
  • 13.1.2 Data Source
• 13.2 Disclaimer

Companion Diagnostic Technologies market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Companion Diagnostic Technologies market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.

Segment by Type
Immunohistochemistry
Molecular Diagnostics

Segment by Application
Oncology
Cardiovascular
Central Nervous System
Auto immune & Inflammation
Virology
Others

By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA

By Company
Dako (Agilent Technologies)
Qiagen
Roche
Abbott Laboratories
Thermo Fisher Scientific
bioMerieux
Myriad Genetics
Resonance Health Ltd.
Leica Microsystems
Abbott Laboratories